All News #Library
Biotech
SOTIO Reveals Positive Non-Human Primate Study Results
12 Nov 2025 //
BUSINESSWIRE
Sotio Announces Promotion of Vivi Boura to Chief Medical Officer
03 Nov 2025 //
BUSINESSWIRE
SOTIO To Showcase Advancements In ADC & Immunocytokine Program
30 Oct 2025 //
BUSINESSWIRE
SOTIO Adds Amy Jensen-Smith, Ulrich Moebius to Leadership Team
02 Oct 2025 //
BUSINESSWIRE
Sotio Reports Promising Preclinical Data on Antibody-Drug Conjuga
29 Apr 2025 //
BUSINESSWIRE
SOTIO Expands ADC Pipeline & Synaffix Collab for Bispecific Candidates
13 Mar 2025 //
BUSINESSWIRE
SOTIO Advances Colorectal ADC SOT109 With Biocytogen Antibodies
09 Jan 2025 //
BUSINESSWIRE
Biocytogen Licenses Human Antibodies To Sotio For Colorectal ADC
09 Jan 2025 //
BUSINESSWIRE
SOTIO Showcases SOT201, VICTORIA-01 & BOXR CAR-T Data at SITC 2024
07 Nov 2024 //
BUSINESSWIRE
Sotio Announces Upcoming Presentations At SITC 2024
22 Oct 2024 //
BUSINESSWIRE
SOTIO And Biocytogen Partner On Multi-Target Antibodies For ADC Pipeline
16 Jul 2024 //
BUSINESSWIRE
Sotio taps Biocytogen to create bispecific ADCs in $326M deal
16 Jul 2024 //
FIERCE BIOTECH
After halting lead asset, Sotio signs $740M deal with Synaffix
17 Oct 2023 //
FIERCE BIOTECH
SOTIO Enters Licensing Agreement With Synaffix to Expand ADC Pipeline
16 Oct 2023 //
PR NEWSWIRE
SOTIO Expands ADC Platform with License to Synaffix’s ADC Technology
16 Oct 2023 //
BUSINESSWIRE
SOTIO Provides Update on Interim Data from Clinical Trials of Nanrilkefusp Alfa
13 Oct 2023 //
BUSINESSWIRE
SOTIO Doses First Patient in AURELIO-05 PII Trial of Nanrilkefusp with Cetuximab
19 Jan 2023 //
GLOBENEWSWIRE

Market Place
Sourcing Support